25.04.2013
- Biogen reported higher-than-expected first quarter profit on Thursday and raised its full year forecasts, and the U.S. biotechnology said it sees its new drug Tecfidera becoming...
25.04.2013
- Dow Chemical posted a better-than-expected 33% jump in quarterly profit as farmers in the Americas bought more of its seeds and pesticides, overshadowing a decline in European...
25.04.2013
- Quarterly results from Exxon Mobil and ConocoPhillips on Thursday showed that while overall growth remained elusive, output rose in key basins in the United States where the oil...
25.04.2013
- AstraZeneca's sales fell by a bigger-than-expected 13% in the first quarter as patent expiries took a heavy toll, underscoring the turnaround challenge facing Britain's second...
25.04.2013
- In the first quarter 2013, Lonza's business performance was solid and in line with expectations. While the Specialty Ingredients market segment showed a good performance, the...
25.04.2013
- Laboratory equipment maker Thermo Fisher Scientific, which this month agreed to acquire Life Technologies for more than $13 billion, on Wednesday reported a higher-than-expected...
25.04.2013
- GlaxoSmithKline is to sell soft drink brands Lucozade and Ribena in a move analysts believe will raise over 1 billion pounds ($1.5 billion) and focus its consumer health business...
24.04.2013
- Novartis has promoted Harry Kirsch, who has driven productivity improvements at its pharmaceuticals division, to be chief financial officer as the Swiss drugmaker looks to grow...
